...
首页> 外文期刊>The Egyptian Rheumatologist >The relationship of serum calprotectin with disease activity, functional status, ultrasonographic findings and radiological damage in rheumatoid arthritis patients
【24h】

The relationship of serum calprotectin with disease activity, functional status, ultrasonographic findings and radiological damage in rheumatoid arthritis patients

机译:血清CalProtectin对类风湿性关节炎患者疾病活动,功能状态,超声波检查和放射性损伤的关系

获取原文
           

摘要

Aim of the workTo measure the levels of serum calprotectin (CLP) in rheumatoid arthritis (RA) patients and to assess its association with disease activity, functional status, ultrasonographic findings, and radiological damage.Patients and methodsThis study included 47 RA patients and 33 controls. The erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (anti-CCP), rheumatoid factor (RF), C-reactive protein (CRP), disease activity score (DAS28), health assessment questionnaire (HAQ), modified Larsen radiological score, musculoskeletal ultrasound and serum CLP levels were assessed.ResultsThe mean age of the patients was 42.5?±?12.8?years; 34 females and 13 males (F:M 2.6:1) with a mean disease duration of 2.6?±?1.1?years. RF was positive in 72%. CLP level was significantly increased in patients compared to control (2.78?±?0.89?μg/ml vs. 0.84?±?0.5?μg/ml; p?
机译:作品的目的测量类风湿性关节炎(RA)患者血清CALPROTECIN(CLP)的水平,并评估其与疾病活动,功能状态,超声检查结果和放射性损伤的关联。患者和方法研究包括47例患者和33例对照。红细胞沉降率(ESR),抗环瓜氨酸肽(抗CCP),类风湿因子(RF),C反应蛋白(CRP),疾病活动评分(DAS28),健康评估问卷(HAQ),改性拉森放射评分,肌肉骨骼超声和血清CLP水平评估。患者的平均年龄是42.5?±12.8?岁; 34雌性和13名男性(F:M 2.6:1),平均疾病持续时间为2.6?±1.1?年。射频在72%中呈阳性。与对照相比,患者的CLP水平显着增加(2.78?±0.89Ω·μg/ ml,0.84±0.5?μg/ ml; p?<0.001)和活性(3.27?±0.75? μg/ ml)与缓解剂(1.92≤≤0.10μg/ ml)相比。在CLP和DAS28,ESR,CRP,HAQ和改性Larsen分数之间检测到显着的相关性(P?<0.001)。在回归,招标和肿胀的关节计数,ESR,CRP,HAQ,修改的Larsen,超声7得分和CLP水平是活动的显着预测因子,但对多变量分析有微不足道。在2.35℃的截止值下,μg/ ml CLP可以显着区分活性RA患者从缓解(AUC 0.95;p≤0.001)的敏感性为90%,特异性100%,精度为95%结论血清CLP水平在RA患者中显着高,这些高水平与疾病活动,功能状况,超声检查和放射学损伤有关。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号